EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Lithium nephrotoxicity: a systematic review and meta-analysis of lithium versus non-lithium control studies in patients with affective disorders

Marie Michele Macaron, Mireilla Abou Rjeily, Raphael Macaron, Asmaa Yehia, Balwinder Singh iD, Mark A Frye, Osama A Abulseoud iD

Therapeutic Advances in Psychopharmacology · 2026-02 · 16

DOI: 10.1177/20451253261419633 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 16.02.2026. Verfasst von Marie Michele Macaron und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, St. George's University of London, London, UK. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lithium, the gold standard treatment of bipolar disorder (BD), is thought to cause nephropathy in long-term users. However, the role of confounding variables linked to BD in exerting this adverse effect remains unclear.

Objectives

This paper evaluates kidney function in patients with affective disorders who are taking lithium compared to patients not on lithium treatment.

Design

This article is a systematic review and meta-analysis. Data sources and methods: A comprehensive search of publications up to October 2023 within Cochrane, Embase, PubMed, Scopus, Web of Science, and CINAHL databases was performed. Three assessors screened and extracted data from eligible observational studies. Risk of bias assessment was done with the ROBINS-E tool. Eligible studies were comparative studies of adult patients with diagnoses of affective disorders, including BD on lithium, with control groups not on lithium, reporting kidney function outcomes.

Results

Mean estimated Glomerular filtration rate (eGFR) showed less favorable outcomes in the lithium group compared to the non-lithium group ( n = 1622, MD = −11.14 ml/min/1.73 m 2 , 95% CI: −16.61, −5.68, I 2 = 86%). The mean annual eGFR decline comparison favored the non-lithium group ( n = 13,280, MD = 0.13 ml/min/1.73 m 2 , 95% CI: 0.06, 0.20, I 2 = 0%). Serum creatinine concentration (mg/dl) was found to be higher in the lithium compared to non-lithium groups ( n = = 1704, MD = 0.05, 95% CI: 0.03, 0.07, I 2 = 3%). New or progressing chronic kidney disease events were not found to be statistically different between the lithium and control groups ( n = = 17,740, OR = 2.16, 95% CI: 0.59, 7.94, I 2 = 99%). The high heterogeneity in this meta-analysis limits the reliability and interpretability of our results.

Conclusion

Kidney function, as measured by eGFR, was decreased in the lithium-taking groups versus the non-lithium groups. Continuous monitoring and discussion of risks and benefits with patients, especially those with a baseline of reduced kidney function, is imperative.

Trial registration

This review was registered prospectively with PROSPERO (CRD42024517414).

Schlagwörter

Stichwörter der Autor:innen

bipolar disorderchronic kidney disease (CKD)lithiumnephrotoxicityrenal function

Autor:innen und Institutionen

  • School of Medicine, St. George's University of London, London, UK.
  • University of Nicosia Medical School, University of Nicosia, Nicosia, Cyprus.
  • School of Medicine, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
  • School of Medicine, McGill University, Montreal, QC, Canada.
  • Department of Medical Physiology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Department of Neuroscience, Graduate School of Biomedical Sciences, Mayo Clinic College of Medicine, Phoenix, AZ, USA.

ORCID-Profile: Balwinder Singh, Osama A Abulseoud

Zitieren

APA

Macaron, M. M., Abou Rjeily, M., Macaron, R., Yehia, A., Singh, B., Frye, M. A., & Abulseoud, O. A. (2026). Lithium nephrotoxicity: a systematic review and meta-analysis of lithium versus non-lithium control studies in patients with affective disorders. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261419633

Vancouver

Macaron MM, Abou Rjeily M, Macaron R, Yehia A, Singh B, Frye MA, et al. Lithium nephrotoxicity: a systematic review and meta-analysis of lithium versus non-lithium control studies in patients with affective disorders. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261419633

BibTeX
@article{Macaron2026,
  author = {Macaron, Marie Michele and Abou Rjeily, Mireilla and Macaron, Raphael and Yehia, Asmaa and Singh, Balwinder and Frye, Mark A and Abulseoud, Osama A},
  title = {Lithium nephrotoxicity: a systematic review and meta-analysis of lithium versus non-lithium control studies in patients with affective disorders},
  journal = {Therapeutic Advances in Psychopharmacology},
  year = {2026},
  volume = {16},
  doi = {10.1177/20451253261419633}
}
Kostenlos starten →